Archives of Breast Cancer (Nov 2018)

What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?

Elmira Ebrahimi,
Reza Shirkoohi

Affiliations

Elmira Ebrahimi: Cancer Biology Research Center, Cancer Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Reza Shirkoohi: Cancer Biology Research Center, Cancer Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

DOI: https://doi.org/10.32768/abc.201854148-149

Abstract

N/A

Published in Archives of Breast Cancer

ISSN: 2383-0433 (Online)
Publisher: Kaviani Breast Disease Institute
Country of publisher: Iran, Islamic Republic of
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://archbreastcancer.com

About the journal